Clinical trial
A Feasibility Study of Tegoprazan and Amoxicillin Dual Therapy for the Treatment of Helicobacter Pylori
NCT06950489 is registered in ClinicalTrials.gov with Soonchunhyang University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Feasibility Study of Tegoprazan and Amoxicillin Dual Therapy for the Treatment of Helicobacter Pylori
- Lead sponsor
- Soonchunhyang University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2025
- Completion date
- December 31, 2025
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
h.pylori infection